Gainers
Neovasc Inc (US) (NASDAQ: NVCN) shares rose 33.35
percent to $1.020 in pre-market trading as the company reported that positive results for Reducer system treatment for refractory
angina were published in The Netherlands Heart Journal.
Fate Therapeutics Inc (NASDAQ: FATE) rose 27.98
percent to $2.15 in pre-market trading as the company reported the FDA Fast Track designation for ProTmune.
Cerus Corporation (NASDAQ: CERS) shares rose 13.16
percent to $6.45 in pre-market trading as the company announced an agreement Sunday with the BARDA for potential funding of up to
$180 million to advance INTERCEPT red blood cell program.
Clean Energy Fuels Corp (NASDAQ: CLNE) rose 9.01
percent to $3.63 in pre-market trading after dropping 2.06 percent on Friday.
Chesapeake Energy Corporation (NYSE: CHK) shares rose
7.76 percent to $4.86 in pre-market trading after rising 6.37 percent on Friday.
ARM Holdings plc (ADR) (NASDAQ: ARMH) rose 5.72
percent to $44.36 in pre-market trading after gaining 0.17 percent on Friday.
Inovio Pharmaceuticals Inc (NYSE: INO) shares rose
5.54 percent to $11.05 in pre-market trading. Inovio Pharmaceuticals and GeneOne Life Science reported that they have received
approval for first-in-man Zika vaccine clinical trial.
Yandex NV (NASDAQ: YNDX) rose 5.18 percent to
$22.54 in pre-market trading after gaining 1.61 percent on Friday.
Vale SA (ADR) (NYSE: VALE) shares rose 3.36 percent
to $4.61 in pre-market trading. Mosaic Co (NYSE: MOS) is
said to be in talks to acquire Vale fertilizer unit, according to sources as reported by Reuters on Friday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
Global Blood Therapeutics Inc (NASDAQ: GBT) shares
fell 2.7 percent to $17.35 in pre-market trading. Global Blood Therapeutics announced a $100 million offering and reported the
initiation of a Phase 2a study of GBT440 in Idiopathic Pulmonary Fibrosis.
Cypress Semiconductor Corporation (NASDAQ: CY)
shares fell 2 percent to $10.41. Cypress reported a proposed $250 million convertible notes offering.
Pan American Silver Corp. (USA) (NASDAQ: PAAS)
shares fell 2.26 percent to $14.69 in pre-market trading after rising 1.01 percent on Friday.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.